These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23231019)

  • 1. Breast surgeon's survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ.
    Blair SL; Emerson DK; Kulkarni S; Hwang ES; Malcarne V; Ollila DW
    Breast J; 2013; 19(1):116-8. PubMed ID: 23231019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lobular carcinoma in situ as a component of breast cancer points to no contraindication for breast-conserving therapy].
    Sautter-Bihl ML
    Strahlenther Onkol; 2001 Jan; 177(1):51-2. PubMed ID: 11200114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast].
    Zinzindohoué C; Bobin JY
    Bull Cancer; 1998 Sep; 85(9):763-72. PubMed ID: 9817060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Despite limited data, coexistent lobular carcinoma in situ should not be a contraindication to breast conservation for women with invasive breast carcinoma.
    Bear HD; Carter WH; Grimes MM
    Cancer; 2000 Mar; 88(5):978-81; discussion 982-3. PubMed ID: 10699883
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carcinoma in situ of the breast].
    Laenkholm AV; Hoffmann J; Rank FE
    Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is excision of all lobular carcinoma in situ really necessary?
    Guenin MA
    Radiology; 2001 Apr; 219(1):295-7. PubMed ID: 11274575
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
    Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S
    Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management for treatment of lobular carcinoma in situ (LCIS)].
    Taruno K; Kinoshita T
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():397-400. PubMed ID: 23350429
    [No Abstract]   [Full Text] [Related]  

  • 10. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor.
    Gabriel H
    AJR Am J Roentgenol; 1999 Aug; 173(2):300-2. PubMed ID: 10430123
    [No Abstract]   [Full Text] [Related]  

  • 11. Lobular carcinoma in situ with microinvasion.
    Nemoto T; Castillo N; Tsukada Y; Koul A; Eckhert KH; Bauer RL
    J Surg Oncol; 1998 Jan; 67(1):41-6. PubMed ID: 9457256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coexistence of breast cystosarcoma phyllodes and bilateral in situ lobular carcinoma].
    Villanueva MJ; Navarro F; Sánchez A; Provencio M
    Rev Clin Esp; 1999 Nov; 199(11):776. PubMed ID: 10638248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgical therapy strategies in carcinoma in situ of the breast].
    Mosny DS
    Praxis (Bern 1994); 1998 Apr; 87(15):516-9. PubMed ID: 9608247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wider excision following core biopsies of lobular neoplasia.
    Elsheikh TM; Silverman JF
    Breast J; 2007; 13(6):631-2, author response 633. PubMed ID: 17983415
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
    Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma.
    Gupta A; Subhas G; Dubay L; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Gorieil Y; Mittal VK
    Am Surg; 2010 Jul; 76(7):731-4. PubMed ID: 20698380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loco-regional treatment of breast carcinoma].
    van Dongen JA; Bartelink H; Bruning PF; Peterse JL
    Ned Tijdschr Geneeskd; 1993 Nov; 137(46):2358-64. PubMed ID: 8264819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Breast-conserving surgery in breast cancer].
    Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F
    G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
    Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.